Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALLINCKRODT PLC

(MNKKQ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société MALLINCKRODT PLC
11/05Regulation FD Disclosure - Form 8-K
PU
11/02Net Debt Leverage Q3 2021 11-02-2021
PU
11/02Non-GAAP Definitions Q3 2021 11-02-2021
PU
11/02Third Quarter Financial Results - Form 8-K
PU
10/28Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations i..
PU
10/26SUBJECT TO FRE 408, STATE LAW EQUIVA : Refresh of 2021 Strategic Plan September 2021 - For..
PU
09/02MALLINCKRODT : Presents Interim Results on Real World Use of Extracorporeal Photopheresis ..
PU
08/03MALLINCKRODT : Net Debt Leverage Q2 2021 08-03-2021
PU
08/03MALLINCKRODT : Non-GAAP Definitions Q2 2021 08-03-2021
PU
08/03MALLINCKRODT : Second Quarter Financial Results (Form 8-K)
PU
07/02MALLINCKRODT : Announces Inclusion of Acthar Gel (Repository Corticotropin Injection) in N..
AQ
07/01MALLINCKRODT : Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in ..
PR
06/24MALLINCKRODT PLC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibi..
AQ
06/14MALLINCKRODT PLC : Regulation FD Disclosure (form 8-K)
AQ
05/04MALLINCKRODT : Presents Data Evaluating Acthar Gel (Repository Corticotropin Injection) fo..
AQ
05/04MALLINCKRODT : 2020 Irish Statutory Accounts
PU
05/04MALLINCKRODT : First Quarter Financial Results
PU
05/04MALLINCKRODT : Net Debt Leverage Q1 2021 05-04-2021
PU
05/04MALLINCKRODT : Non-GAAP Definitions Q1 2021 05-04-2021
PU
05/04MALLINCKRODT : Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
05/03MALLINCKRODT : Presents Data Evaluating INOmax (Nitric Oxide) Gas, for Inhalation in a Pha..
AQ
05/03MALLINCKRODT : Presents Data Evaluating Acthar® Gel (Repository Corticotropin Injection) f..
PR
05/02MALLINCKRODT : Acthar Gel Phase 4 Keratitis ARVO Poster
PU
04/30MALLINCKRODT : Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Ph..
PR
03/24MALLINCKRODT : Supports Healthcare Businesswomen's Association as Two Employees Honored wi..
PU
03/22MALLINCKRODT : Announces U.S. Food and Drug Administration (FDA) Approves Updated Acthar® ..
PU
03/17MALLINCKRODT : Announces 2021 Advancing Extracorporeal Photopheresis Immunomodulation Inve..
PU
03/10MALLINCKRODT : Non-GAAP Definitions Q4 2020 03-10-2021
PU
03/10MALLINCKRODT : Net Debt Leverage Q4 2020 03-10-2021
PU
03/08MALLINCKRODT : Initial Insider Trading Report (SEC Filing - 3)
PU
02/10MALLINCKRODT : Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
PU
01/28MALLINCKRODT : Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis Syst..
PU
2020MALLINCKRODT : Non-GAAP Definitions Q3 2020 11-03-2020
PU
2020MALLINCKRODT : Net Debt Leverage Q3 2020 11-03-2020
PU
2020MALLINCKRODT : Secures Broad Consensus with Key Stakeholders on Comprehensive Chapter 11 R..
AQ
2020MALLINCKRODT PLC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership,..
AQ
2020NXP, Matson rise; Advanced Micro Devices, Mallinckrodt fall
AQ
2020NXP, Matson rise; Advanced Micro Devices, Mallinckrodt fall
AQ
2020MALLINCKRODT : Receives a Complete Response Letter from the U.S. Food and Drug Administrat..
AQ
2020MALLINCKRODT PLC : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
2020MALLINCKRODT : Announces 2020 Investigator Award to Further Advances in ECP Immunomodulati..
AQ
2020MALLINCKRODT : Hobart, N.Y. Site Recognized With Two Manufacturing Leadership Awards
PR
2020MALLINCKRODT : Announces U.S. FDA Filing Acceptance of Biologics License Application for S..
AQ
2020MALLINCKRODT : Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
2020MALLINCKRODT : 2Q Earnings Snapshot
AQ
2020MALLINCKRODT PLC : Reports Earnings for the Second Quarter 2020 and Highlights Pipeline Ad..
PR
2020MALLINCKRODT PLC : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
2020MALLINCKRODT : to Report Earnings Results for Second Quarter 2020
PR
2020MALLINCKRODT : Confirms that U.S. Food and Drug Administration Will Convene an Advisory Co..
AQ
2020MALLINCKRODT : to Present at the BMO Prescriptions for Success Healthcare Conference Jun 1..
AQ
2020MALLINCKRODT : to Present at the BMO Prescriptions for Success Healthcare Conference
PR
2020MALLINCKRODT : to Proceed with Appeal Despite Appellate Court Decision Denying Temporary I..
AQ
2020MALLINCKRODT : to Present Phase 3 StrataGraft Regenerative Skin Tissue Clinical Trial Resu..
AQ
2020MALLINCKRODT PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020MALLINCKRODT : to Proceed with Appeal Despite Appellate Court Decision Denying Temporary I..
PR
2020MALLINCKRODT : Real-World Data of Terlipressin in Hospitalized Patients in U.K. with Hepat..
PR
2020MALLINCKRODT : Completes Rolling Submission of Biologics License Application for StrataGra..
AQ
2020MALLINCKRODT : Will Appeal District Court Ruling in Case Involving Ongoing Acthar Medicaid..
AQ
2020MALLINCKRODT : Will Appeal District Court Ruling in Case Involving Ongoing Acthar Medicaid..
PR
2020MALLINCKRODT : Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
2020MALLINCKRODT : Reports Earnings for the First Quarter 2020 and Highlights Pipeline Progres..
AQ
2020MALLINCKRODT : 1Q Earnings Snapshot
AQ
2020MALLINCKRODT PLC : Reports Earnings for the First Quarter 2020 and Highlights Pipeline Pro..
PR
2020MALLINCKRODT : Announces Positive Findings in INOmax® (Nitric Oxide) Gas, for Inhalation P..
PR
2020MALLINCKRODT : Supports Investigator-Initiated Study at Massachusetts General Hospital to ..
AQ
2020MALLINCKRODT : Supports Investigator-Initiated Study at Massachusetts General Hospital to ..
PR
2020MALLINCKRODT : Announces U.S. Food and Drug Administration Filing Acceptance of New Drug A..
AQ
2020MALLINCKRODT : to Report Earnings Results for First Quarter 2020
PR
2020MALLINCKRODT : Announces Publication of Data on Acthar Gel from its Randomized, Double-Bli..
AQ
2020MALLINCKRODT PLC : Entry into a Material Definitive Agreement, Termination of a Material D..
AQ
2020MALLINCKRODT : Initiates Rolling Submission of Biologics License Application for StrataGra..
AQ
2020MALLINCKRODT : and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of ..
AQ
2020MALLINCKRODT : and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of ..
AQ
2020MALLINCKRODT PLC : Other Events (form 8-K)
AQ
2020MALLINCKRODT : Completes Rolling Submission of New Drug Application to the U.S. Food and D..
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on MALLINCKRODT PLC
05/10/22